Biblio

Van de Wyngaert Z, Nerich V, Fouquet G, Chretien M-L, Caillot D, Azar N, Garderet L, Lenain P, Macro M, Bourhis J-H et al..  2020.  Cost and efficacy of peripheral stem cell mobilization strategies in multiple myeloma. BONE MARROW TRANSPLANTATION. 55:2254-2260.

Van de Wyngaert Z, Nerich V, Fouquet G, Chretien M-L, Caillot D, Azar N, Garderet L, Lenain P, Macro M, Bourhis J-H et al..  2020.  Cost and efficacy of peripheral stem cell mobilization strategies in multiple myeloma. BONE MARROW TRANSPLANTATION. 55:2254-2260.

Muggeo E., Boissel A., Martin L., Sgro C., Michiels C..  2015.  Cost comparison of two reprocessing procedures of flexible ureteroscopes at the University Hospital of Dijon. PROGRES EN UROLOGIE. 25:318-324.

Savary P, Foltete JChristophe, Garnier S.  Submitted.  Cost distances and least cost paths respond differently to cost scenario variations: a sensitivity analysis of ecological connectivity modeling. INTERNATIONAL JOURNAL OF GEOGRAPHICAL INFORMATION SCIENCE.

Jeanmaire T, Clinard F, Binquet C, Catelinois O, Collignan B, Tillier C, Lejeune C.  2016.  Cost effectiveness analysis of radon prevention programmes in Franche-Comte. ENVIRONNEMENT RISQUES & SANTE. 15:410-418.

Law-Ki C., Robineau C., Garnier N., Guenfoudi M.-P, Lazzarotti A., Cheynel N., Cailliod R., Ortega-Deballon P..  2018.  Cost of complex abdominal wall reconstruction with biological prostheses in a French public hospital. JOURNAL OF VISCERAL SURGERY. 155:349-353.

Fromont A., Lehanneur M.-N, Rollot F., Weill A., Clerc L., C. Kopp B, Binquet C., Moreau T..  2014.  Cost of multiple sclerosis in France. REVUE NEUROLOGIQUE. 170:432-439.

Delmas M, Garcia S.  2018.  The cost of the diagnosis. The invisible work of mothers with cognitively disabled children. ANTHROPOLOGIE ET SANTE-REVUE INTERNATIONALE FRANCOPHONE D ANTHROPOLOGIE DE LA SANTE. 17

Darmaputra DC, Zaman FY, Khu YLi, Nagalingam V, Liew D, Aung AKar.  2021.  Cost-analysis of opportunistic influenza vaccination in general medical inpatients. INTERNAL MEDICINE JOURNAL. 51:591-595.

Belaiche R, Liu Y, Migniot C, Ginhac D, Yang F.  2020.  Cost-Effective CNNs for Real-Time Micro-Expression Recognition. APPLIED SCIENCES-BASEL. 10:4959.

Maunoury F, Clement A, Nwankwo C, Levy-Bachelot L, Abergel A, Di Martino V, Thervet E, Durand-Zaleski I.  2018.  Cost-effectiveness analysis of elbasvir-grazoprevir regimen for treating hepatitis C virus genotype 1 infection in stage 4-5 chronic kidney disease patients in France. PLOS ONE. 13:e0194329.

Pelloux-Prayer R, Schiele P, Oudard S, Gravis G, Kleinclauss F, Crehange G, Hennequin C, Morgans AK, Geoffrois L, Limat S et al..  2021.  Cost-effectiveness Analysis of Innovative Therapy for Patients with Newly Diagnosed Hormone-Sensitive Metastatic Prostate Cancer. CLINICAL GENITOURINARY CANCER. 19:E326-E333.

Pelloux-Prayer R., Schiele P., Oudard S., Gravis G., Kleinclauss F., Crehange G., Hennequin C., Morgans A., Geoffrois L., Limat S. et al..  2022.  COST-EFFECTIVENESS ANALYSIS OF INNOVATIVE THERAPY FOR PATIENTS WITH NEWLY DIAGNOSED HORMONE-SENSITIVE METASTATIC PROSTATE CANCER. VALUE IN HEALTH. 25:S113.

Paillard M-J, Curtit E, Nerich V, Cals L, Bazan F, Mansi L, Meneveau N, Montcuquet P, Dobi E, Chaigneau L et al..  2014.  Cost-effectiveness analysis of routine use of eribulin in patients with metastatic breast cancer in France: A retrospective analysis.. JOURNAL OF CLINICAL ONCOLOGY. 32

Paix A., Thillays F., Biau J., Vulquin N., Pop I., Debbi K., Grosu A.L, Sauleau E.A, Noel G..  2019.  Cost-effectiveness analysis of stereotactic radiotherapy in colorectal cancer brain metastases. RADIOTHERAPY AND ONCOLOGY. 133:S891.

Paix A., Thillays F., Courtault-Deslandes F., Pop I., Biau J., Briard O., Grosu A.L, Sauleau E.A, Noel G..  2019.  Cost-effectiveness analysis of stereotactic radiotherapy in melanoma brain metastases.. RADIOTHERAPY AND ONCOLOGY. 133:S456-S457.

Nerich V, Fleck C, Chaigneau L, Isambert N, Borg C, Kalbacher E, Jary M, Simon P, Pivot X, Blay J-Y et al..  2017.  Cost-Effectiveness Analysis of Tyrosine Kinase Inhibitors for Patients with Advanced Gastrointestinal Stromal Tumors. CLINICAL DRUG INVESTIGATION. 37:85-94.

Labopin M, Ruggeri A, Gorin NClaude, Gluckman E, Blaise D, Mannone L, Milpied N, Yakoub-Agha I, Deconinck E, Michallet M et al..  2014.  Cost-effectiveness and clinical outcomes of double versus single cord blood transplantation in adults with acute leukemia in France. HAEMATOLOGICA. 99:535–540.

Campos NG, Lince-Deroche N, Chibwesha CJ, Firnhaber C, Smith JS, Michelow P, Meyer-Rath G, Jamieson L, Jordaan S, Sharma M et al..  2018.  Cost-Effectiveness of Cervical Cancer Screening in Women Living With HIV in South Africa: A Mathematical Modeling Study. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES. 79:195-205.

Desplanches T, Lejeune C, Cottenet J, Sagot P, Quantin C.  2018.  Cost-effectiveness of diagnostic tests for threatened preterm labor in singleton pregnancy in France. COST EFFECTIVENESS AND RESOURCE ALLOCATION. 16:21.

Maunoury F., Clement A., Elbasha E.H, Abergel A., Di Martino V., Thervet E., Levy-Bachelot L., Durand-Zaleski I..  2017.  Cost-effectiveness of elbasvir-grazoprevir association for treating hepatitis C virus genotype 1 infection in stage 4-5 chronic kidney disease patients in France. JOURNAL OF HEPATOLOGY. 66:S315.

Lejeune C, Le Gleut K, Cottet V, Galimard C, Durand G, Dancourt V, Faivre J.  2014.  The cost-effectiveness of immunochemical tests for colorectal cancer screening. DIGESTIVE AND LIVER DISEASE. 46:76-81.

Loubiere S, Drezet A, Beau-Faller M, Moro-Sibilot D, Friard S, Wislez M, Blons H, Daniel C, Westeel V, Madroszyk A et al..  2018.  Cost-effectiveness of KRAS, EGFR and ALK testing for decision making in advanced nonsmall cell lung carcinoma: the French IFCT-PREDICT.amm study. EUROPEAN RESPIRATORY JOURNAL. 51:1701467.

Binquet C, Lejeune C, Seror V, Peyron F, Bertaux A-C, Scemama O, Quantin C, Bejean S, Stillwaggon E, Wallon M.  2019.  The cost-effectiveness of neonatal versus prenatal screening for congenital toxoplasmosis. PLOS ONE. 14:e0221709.

Bouamra B., E. de Bustos M, Vuillier F., Montiel P., Bonnet L., Moulin T..  2015.  Cost-effectiveness of telestroke in five organizational scenarios in Franche-Comte (France). INTERNATIONAL JOURNAL OF STROKE. 10:353.